QS Research · Michael Burry's Scion Capital analyst template · 2006
C3.ai, Inc. (AI)
As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data
Report price $10.68 (close 2026-11-16); latest close $9.13 (2026-11-20), -14.5% since the report; figures re-marked at the latest close
Conclusion: WATCH
Conviction low · base case none · downside -11% · upside +28%
At $10.68 the market is paying 4.59x TTM sales for a business with TTM revenue of $232.4M, TTM EBIT of -$471.9M and TTM free cash flow of -$155.8M; the balance sheet holds $651.1M of cash and short-term investments and no debt, but $258.2M of TTM stock-based compensation is larger than revenue, so GAAP profitability remains out of reach on the current share plan. The call is PASS with low conviction because the two-sided case set does not offer an adequate edge: the downside is $8.16, -23.6%, on -25.0% sales at a compressed EV/Sales of 3.79x, while the upside is $11.67, +9.3%, on +15% sales at today's EV/Sales of 4.59x. There is no base case: no independent multiple is available, since no comparable peer multiple sets one, and a base at today's multiple is today's price by construction. With the downside larger than the upside and no base case to anchor value, the shares do not meet the bar for a positive or negative stance; the crowded short interest of 26.2% of shares outstanding and 29.8% of the float is a squeeze risk, not a value case.
Key numbers
- Share price: $9.13
- Market cap: $1.47B
- Latest financial period: TTM to Jul 31, 2026
- Revenue (TTM): $232.4M
- FCF yield: -10.6%
- Price / book: 2.11x
- Earnings-quality flags (TTM): none flagged
- Revenue growth (latest fiscal year): -35.7%
- ROIC (TTM): -363.7%
- WACC: 13.7%
- Economic profit spread: -377.4 pts
The 15 boxes
- ✓ 1. Long-form business notes
C3.ai sells enterprise AI application software: subscriptions (licenses, SaaS, stand-ready COE support, initial production deployments, runtime/hosting) plus professional services, with the substantial majority of revenue from subscriptions and a sales cycle that starts with a paid initial production deployment of up to six months before converting to consumption-based or multi-period commitments. Revenue went $183.2M in FY2021, $310.6M in FY2024, $389.1M in FY2025, then $250.3M in FY2026 and $232.4M on a TTM basis to 2026-07-31, with gross profit falling from $235.9M (FY2025) to $77.4M (FY2026) and operating income of -$498.5M in FY2026. Between the FY2021 10-K and the latest one the product story changed from C3 AI Suite / Ex Machina / CRM naming to a five-layer stack built around the C3 Agentic AI Platform, C3 Generative AI and C3 Code, and the go-to-market language shifted to fewer, more selective IPD agreements while U.S. Federal became a stated growth segment. Cash consumption is operating, not capital: operating cash flow was -$190.2M in FY2026 and -$154.6M TTM against capex of $1.9M and $1.2M respectively.
- ✓ 2. Competitive advantage
The sources do not show a durable competitive advantage. Management claims no directly competitive end-to-end platform, but it describes primary competition as DIY internal IT builds using AWS, Microsoft Azure or Google Cloud plus point tools and integrators such as Accenture, Capgemini, Lockheed Martin and Booz Allen; customers have no renewal obligation and average contract value is decreasing. The financial record is negative: revenue fell from $389.1M in FY2025 to $250.3M in FY2026, operating income was -$498.5M in FY2026 and -$471.9M TTM, net income was -$470.4M in FY2026, and operating cash flow was -$190.2M in FY2026. Patents exist, but no source ties them to pricing power or share.
- ✓ 3. 10-Q takeaways
The quarter ended July 31, 2026 (Q1 FY2027) shows revenue still shrinking — total revenue of $52.4M versus $70.3M a year earlier, down 25% — but a much smaller cost base: GAAP gross margin 32% versus 38%, operating expenses down 24% to $114.9M, and GAAP loss from operations of $98.3M versus $124.8M. Cash became the story: net cash provided by operating activities and free cash flow were each $2.1M, and cash, cash equivalents and marketable securities were $651.1M, up $76M quarter over quarter, while RPO slipped to $200.0M from $203.1M at April 30, 2026. Management gave numeric guidance (Q2 FY2027 revenue $51.0–$55.0M, FY2027 $210.0–$240.0M) and reported bookings up 73% quarter over quarter with no dollar amount disclosed. The GAAP net loss of $92.8M still includes $59.2M of stock-based compensation and $0.7M of restructuring charges, so the operating result remains a loss.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.